<DOC>
	<DOC>NCT02785146</DOC>
	<brief_summary>A randomized, paralleled control clinical study investigating Huaier Granule for prevention of recurrence and metastasis of colorectal cancer after radical surgery, to evaluate the efficacy and safety.</brief_summary>
	<brief_title>Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>The subjects volunteer to sign the informed consent Aged: 18 to 75 years old Colorectal cancer (AJCCTNM, highrisk Stage II and Stage III) The diagnosis and colorectal cancer has been confirmed by pathological examination after radical surgery The liver and kidney function satisfies the following conditions within 15 days after surgery (excluding day 15): aspartate aminotransferase (AST), glutamicoxalacetic transaminase (ALT), alkaline phosphatase (ALP)&lt; 2 upper limit of normal (ULN), total bilirubin ≤ 1.5 ULN, serum creatinine &lt; 1.5 ULN; normal coagulation function Other laboratory tests meet the following requirements within 15 days after surgery (excluding day 15): white blood cells count ≥ 3.0×109/L, absolute neutrophil count ≥ 1.5×109/L, platelet count ≥ 100×109/L ECOG：02 points No other previous history of malignancy. Multiple primary cancer Not recover from the colorectal surgery Presence of organ, bone, or skin metastases Pregnant or lactating women Those with active bleeding due to various reasons Those with HIV infection or AIDSassociated diseases Those with severe acute and chronic diseases Those with severe diabetes Those with serious infectious diseases Those who can not take drugs by oral route Drug abusers or those with psychological or mental diseases that may interfere with study compliance Conditions that are considered not suitable for this study investigators</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Huaier Granule</keyword>
	<keyword>After radical surgery</keyword>
	<keyword>Prevention of recurrence and metastasis</keyword>
	<keyword>Efficacy and safety</keyword>
</DOC>